INDOLINONE COMPOUNDS FOR USE AS MAP4K1 INHIBITORS
The present disclosure is directed to compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein ring A, ring C, X1, X2, L1, R1, R2, R3, R4, R5, R6, R7, m and n are as defined herein, which are useful as MAP4K1 inhibitors, processes for their preparation, pharmaceutical composit...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | DHONE, Sachin, Vasantrao CHAUDHARI, Sachin Sundarlal ADIK, Bharat, Gangadhar GHARAT, Laxmikant, Atmaram WADEKAR, Prashant, Dilip IYER, Pravin GOWDA, Nagaraj BAJPAI, Malini |
| description | The present disclosure is directed to compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein ring A, ring C, X1, X2, L1, R1, R2, R3, R4, R5, R6, R7, m and n are as defined herein, which are useful as MAP4K1 inhibitors, processes for their preparation, pharmaceutical compositions comprising the compounds, and the use of the compounds or the compositions in the treatment or prevention of various diseases, conditions and/or disorders mediated by MAP4K1. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_ZA202102259B</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ZA202102259B</sourcerecordid><originalsourceid>FETCH-epo_espacenet_ZA202102259B3</originalsourceid><addsrcrecordid>eNrjZDD09HPx9_H08_dzVXD29w3wD_VzCVZw8w9SCA12VXAMVvB1DDDxNlTw9PPwdPIM8Q8K5mFgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcUFicmpeakl8VGORgZGhgZGRqaWTsbEqAEASq4mdA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>INDOLINONE COMPOUNDS FOR USE AS MAP4K1 INHIBITORS</title><source>esp@cenet</source><creator>DHONE, Sachin, Vasantrao ; CHAUDHARI, Sachin Sundarlal ; ADIK, Bharat, Gangadhar ; GHARAT, Laxmikant, Atmaram ; WADEKAR, Prashant, Dilip ; IYER, Pravin ; GOWDA, Nagaraj ; BAJPAI, Malini</creator><creatorcontrib>DHONE, Sachin, Vasantrao ; CHAUDHARI, Sachin Sundarlal ; ADIK, Bharat, Gangadhar ; GHARAT, Laxmikant, Atmaram ; WADEKAR, Prashant, Dilip ; IYER, Pravin ; GOWDA, Nagaraj ; BAJPAI, Malini</creatorcontrib><description>The present disclosure is directed to compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein ring A, ring C, X1, X2, L1, R1, R2, R3, R4, R5, R6, R7, m and n are as defined herein, which are useful as MAP4K1 inhibitors, processes for their preparation, pharmaceutical compositions comprising the compounds, and the use of the compounds or the compositions in the treatment or prevention of various diseases, conditions and/or disorders mediated by MAP4K1.</description><language>eng</language><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220428&DB=EPODOC&CC=ZA&NR=202102259B$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76294</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220428&DB=EPODOC&CC=ZA&NR=202102259B$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>DHONE, Sachin, Vasantrao</creatorcontrib><creatorcontrib>CHAUDHARI, Sachin Sundarlal</creatorcontrib><creatorcontrib>ADIK, Bharat, Gangadhar</creatorcontrib><creatorcontrib>GHARAT, Laxmikant, Atmaram</creatorcontrib><creatorcontrib>WADEKAR, Prashant, Dilip</creatorcontrib><creatorcontrib>IYER, Pravin</creatorcontrib><creatorcontrib>GOWDA, Nagaraj</creatorcontrib><creatorcontrib>BAJPAI, Malini</creatorcontrib><title>INDOLINONE COMPOUNDS FOR USE AS MAP4K1 INHIBITORS</title><description>The present disclosure is directed to compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein ring A, ring C, X1, X2, L1, R1, R2, R3, R4, R5, R6, R7, m and n are as defined herein, which are useful as MAP4K1 inhibitors, processes for their preparation, pharmaceutical compositions comprising the compounds, and the use of the compounds or the compositions in the treatment or prevention of various diseases, conditions and/or disorders mediated by MAP4K1.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDD09HPx9_H08_dzVXD29w3wD_VzCVZw8w9SCA12VXAMVvB1DDDxNlTw9PPwdPIM8Q8K5mFgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcUFicmpeakl8VGORgZGhgZGRqaWTsbEqAEASq4mdA</recordid><startdate>20220428</startdate><enddate>20220428</enddate><creator>DHONE, Sachin, Vasantrao</creator><creator>CHAUDHARI, Sachin Sundarlal</creator><creator>ADIK, Bharat, Gangadhar</creator><creator>GHARAT, Laxmikant, Atmaram</creator><creator>WADEKAR, Prashant, Dilip</creator><creator>IYER, Pravin</creator><creator>GOWDA, Nagaraj</creator><creator>BAJPAI, Malini</creator><scope>EVB</scope></search><sort><creationdate>20220428</creationdate><title>INDOLINONE COMPOUNDS FOR USE AS MAP4K1 INHIBITORS</title><author>DHONE, Sachin, Vasantrao ; CHAUDHARI, Sachin Sundarlal ; ADIK, Bharat, Gangadhar ; GHARAT, Laxmikant, Atmaram ; WADEKAR, Prashant, Dilip ; IYER, Pravin ; GOWDA, Nagaraj ; BAJPAI, Malini</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_ZA202102259B3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>online_resources</toplevel><creatorcontrib>DHONE, Sachin, Vasantrao</creatorcontrib><creatorcontrib>CHAUDHARI, Sachin Sundarlal</creatorcontrib><creatorcontrib>ADIK, Bharat, Gangadhar</creatorcontrib><creatorcontrib>GHARAT, Laxmikant, Atmaram</creatorcontrib><creatorcontrib>WADEKAR, Prashant, Dilip</creatorcontrib><creatorcontrib>IYER, Pravin</creatorcontrib><creatorcontrib>GOWDA, Nagaraj</creatorcontrib><creatorcontrib>BAJPAI, Malini</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>DHONE, Sachin, Vasantrao</au><au>CHAUDHARI, Sachin Sundarlal</au><au>ADIK, Bharat, Gangadhar</au><au>GHARAT, Laxmikant, Atmaram</au><au>WADEKAR, Prashant, Dilip</au><au>IYER, Pravin</au><au>GOWDA, Nagaraj</au><au>BAJPAI, Malini</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>INDOLINONE COMPOUNDS FOR USE AS MAP4K1 INHIBITORS</title><date>2022-04-28</date><risdate>2022</risdate><abstract>The present disclosure is directed to compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein ring A, ring C, X1, X2, L1, R1, R2, R3, R4, R5, R6, R7, m and n are as defined herein, which are useful as MAP4K1 inhibitors, processes for their preparation, pharmaceutical compositions comprising the compounds, and the use of the compounds or the compositions in the treatment or prevention of various diseases, conditions and/or disorders mediated by MAP4K1.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_ZA202102259B |
| source | esp@cenet |
| title | INDOLINONE COMPOUNDS FOR USE AS MAP4K1 INHIBITORS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T01%3A06%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=DHONE,%20Sachin,%20Vasantrao&rft.date=2022-04-28&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EZA202102259B%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |